Friday, October 17, 2014

India Micro Small and Medium Enterprises Market Outlook to 2018 -Focus on Auto-Components and Plastic Manufacturing Segment

India Micro Small and Medium Enterprises Market Outlook to 2018 -Focus on Auto-Components and Plastic Manufacturing Segment provides a comprehensive analysis of the market size of the India MSME Sector on the basis of its segments which includes auto components and plastic manufacturing. The report entails market size and segmentations of SME auto components and SME plastic industry. The future analysis and segmentation by various clusters and by contribution of different sectors have also been discussed. The report also provides the major growth drivers and growth constraints of SMEs in India observed over the last few years. Future outlook of this market in the country has been provided on the basis of output turnover and its dependence on the macroeconomic factors.

India Micro Small and Medium Enterprises Market 
The MSME sector has been the mainstay of the Indian economy by providing the second largest share of employment to Indian population after agriculture. MSMEs have reduced regional imbalances by helping the industrialization of rural and backward areas. Setting up MSMEs in rural areas has helped in equitable distribution of wealth and income which has resulted in parity between urban and rural population in India. The MSME sector market size has been defined on the basis of production value of all the MSMEs in India during FY’2008-FY’2014.

The auto components industry has been one of the fastest growing segments in India’s manufacturing sector. The growth has been stimulated by the large number of SMEs operating in the auto components industry across India. The SMEs operate in various clusters which have been formed as a result of policy support provided by the government. The existence of policy support has not precisely translated into infrastructural support as SMEs have been facing numerous problems related to infrastructure, machinery, road network and electricity. The inefficient implementation of government policies has resulted in industry registering a low CAGR of ~% during FY’2008-FY’2014.

The plastic processing in India is primarily done by small scale manufacturers who operate in clusters across India. The government of India helps in the development of clusters by providing SMEs with infrastructure, technological and policy support. The domestic downstream or the plastic processing industry encompasses three broad manufacturing processes which include extrusion, injection molding, blow molding and blow molding. The plastic processing industry has been growing steadily over the period FY’2008-FY’2014 as it recorded a CAGR of ~%.

Key Topics Covered in the Report:
·         Market Size of the India MSME Sector by production value, FY’2008-FY’2014.
·         Market Segmentation of the India MSME Sector by Type of Industry, FY’2008-FY’2014.
·         Market Segmentation of India SME Auto Components Industry on the Basis of Various Clusters, FY’2008-FY’2014.
·         Market Segmentation of India SME Plastic Manufacturing Industry on the Basis of Various Clusters, FY’2008-FY’2014
·         Growth Drivers and Growth Constraints of the India SME Auto Components Industry
·         Growth Drivers and Growth Constraints of the SME Plastic Manufacturing Industry
·         Future Outlook and Projections of the India SME Auto Components Industry on the basis of output turnover, FY’2015-FY’2019.

·         Future Outlook and Projections of the India SME Plastic Manufacturing Industry on the basis of output turnover, FY’2015-FY’2019. 


Contact
Ken Research
Information Department
info@kenresearch.com
+91-11-47017199


Monday, October 13, 2014

Europe Medical Device Market Outlook to 2018 – Driven by the Presence of Advanced Healthcare Industry and Ageing Population

Europe Medical Device Market Outlook to 2018 – Driven by the Presence of Advanced Healthcare Industry and Ageing Population presents a comprehensive analysis of the industry aspects including market size by production value of medical devices market in Europe. The report also entails market share analysis and company profiles of major players operating in the medical devices market in Europe. The medical device market of Europe is mainly comprised of medical equipments such as consumables, orthopaedic devices, dental devices, respiratory devices, and ophthalmic devices which are manufactured in Germany, France, the UK, Italy and Spain. The future analysis, trends and developments, government regulations and segmentation by application have also been discussed in the industry research report.  

Europe Medical Devices Industry
The demand for medical devices has been growing owing to a mounting awareness for early diagnosis and treatment of countless disease states in European countries. Other factors propelling the escalating demand for medical devices are the ageing populace, growth in the number of better informed patients and the accessibility of enhanced technologies. In the recent years, medical devices industry in Europe has witnessed a continuous growth.

The key countries that have contributed significantly to the Europe medical devices market during 2008-2013 include Germany, UK and France. Germany is one of the major European markets and it has been observed that the country contributes immensely to the exports of medical devices. An increased investment in R&D on healthcare has played a fundamental role in the economic growth of Germany as it has resulted in improved health outcomes and extended years of life.

The increasing exports of medical devices, augmenting purchasing power for medical care and increasing demand for innovative medical devices were the key factors supporting the growth of medical devices in Europe. The overall production value witnessed by the market grew from EUR ~ million in 2008 to EUR ~ million in 2013, growing at a CAGR of 2.6% during 2008-2013.
Over the past several years, medical device market has constantly been a field of significant innovation, and this endeavor has played a central role in the early detection, diagnosis and treatment of disease.


The rising incidences of chronic diseases in Europe such as diabetes, hypertension, osteoporosis and other age related diseases will necessitate enhanced products and long-term, post-sales service. Market participants will be required to develop solutions best matched to customer needs to continue to be competitive. Owing to the prevalence of high competition and mounting costs of medical devices products and services, enhanced sales and market strategies will be required, together with long-term partnerships with companies. The overall medical devices market in Europe is projected to reach EUR ~ million in 2018, augmenting at a CAGR of 3.9% during 2013-2018.  

Key Topics Covered in the Report
·         Europe medical devices market size.
·         The country wise segmentation of medical device industry of Europe.
·         The market size, future outlook and projections of the medical device industry of Germany, France, the UK, Italy and Spain.
·         Market segmentation by the type of equipments of Germany, France, the UK, Italy and Spain
·         The market size and segmentation of the medical device industry of Germany for general medical instruments and appliances, medical and electrodiagnostics devices, medical consumables, dental devices, ophthalmic devices, respiratory devices and other medical devices used in the field of cardiology and neurology.      
·         Future Outlook and Projections of Germany Medical Device Market by Equipments
·         The market size and segmentation of the medical devices market of France for medical and electrodiagnostics devices, consumables, dental devices, orthopaedic devices, respiratory and ophthalmic devices market.
·         Future Outlook and Projections of France Medical Device Market by Equipments
·         The market size and segmentation of the medical device industry of the UK for consumables, medical and electro diagnostics instrument, orthopaedic devices, dental devices, respiratory, ophthalmic instruments and patient aids market.
·         Future Outlook and Projections of the UK Medical Device Market by Equipments
·         The market size and segmentation of the medical device industry of Italy for consumables, medical and electro diagnostics instrument, orthopaedic devices, dental devices, respiratory and ophthalmic instruments market.
·         Future Outlook and Projections of Italy Medical Device Market by Equipments
·         The market size and future outlook and projections of the medical device market of Spain.
·         Spain medical device market segmentation by equipment including medical devices for single use, electro medical devices, dental devices, orthopaedics, respiratory and other related therapies, cardiology, ophthalmic goods and instruments and neurology.  
·         Trends and developments of the medical device industry of European region, Germany, the UK, France, Italy and Spain.
·         Exports and Imports by different equipments in Germany, France, the UK, Italy and Spain
·         Growth Drivers of Europe medical devices
·         Profiles of major players in medical device market of Europe
·         Future outlook and projections of Europe medical device market.


Contact:
Ken Research
Information Department
info@kenresearch.com
+91-11-4701 7199

Tuesday, September 30, 2014

▶ China Insulin Market Analysis to 2018 - Research Report by Ken Research - Video Dailymotion

▶ China Insulin Market Analysis to 2018 - Research Report by Ken Research - Video Dailymotion



  •           Future Growth of the insulin market will be led
    by greater consumption of analog insulin
  •          Market leaders are concentrating upon R&D
    in the country



Ken
Research
announced its latest publication on “China Insulin Market Review to 2018 - Increasing Focus on R&D
Investments
” which provides a comprehensive analysis of major types of
insulin consumed in the country. The report covers various aspects such as
market size of China’s insulin market, segmentation on the basis of insulin
replacement therapy, types of insulin, usage by type of diabetes and future
outlook of the market. The report is useful for insulin manufacturers and
distributors, as well as new players venturing in the market.

In view of China
accounting for the largest patient pool of diabetes in the world, in addition
to the growing spending power of the population, insulin majors such as Novo
Nordisk, Eli Lilly and Company and Sanofi are intensifying their R&D and
production activities in the country.  In
order to provide products that are more localized that suit the specific needs
of China’s diabetic population, companies are increasingly investing towards
R&D in the country.     

According to the
research report, the Chinese insulin market will grow rapidly, thereby exceeding
USD 3 billion by 2018, largely due to rapidly increasing consumption of analog
insulin in the country.

“Since China is
on its way to become the largest market for insulin in the Asia Pacific as well
as globally, insulin companies are strengthening their R&D in the country”,
according
to the Research Associate, Ken Research.

Key
Topics Covered in the Report:
-         
China Insulin Market Size by Volume and Value
-         
Market Segmentation by insulin replacement
therapy and types of insulin
-         
Trends and growth drivers   
-         
Competition and Market Share
-         
Future Outlook
-         
Macro Economic Parameters
Key
Products Mentioned in the Report
Human Insulin
Analog Insulin
Premix Insulin
Rapid Acting Insulin
Long Acting Insulin

Companies
Covered in the Report
Novo Nordisk
Eli Lilly and Company
Sanofi Aventis
BJ Ganli Pharmaceuticals
Tonghua Dongbao


Related Reports:



Contact:

Ken Research

Information Department

info@kenresearch.com

+91-011-47017199



Healthcare Report - India Future Insulin Market Trends and Growth - Video Dailymotion

Healthcare Report - India Future Insulin Market Trends and Growth - Video Dailymotion



India Insulin Market
Review to 2018 - Intensifying Strategic Alliances Between Companies’

presents a comprehensive analysis of market size by value of major types of
insulin consumed in India. The report entails the segment wise market share
analysis and company profiles of major players in the insulin market in India.
The future analysis of the market has also been discussed in the report.

The diabetic population in India is largely treated with
human insulin solely due to the fact that it is cheaper as compared to analog
insulin. In FY’2013, human insulin held ~% of the total insulin market in India,
generating revenue of USD ~ million. The revenue from human insulin registered
a CAGR of 10.5% during FY’2008-FY’2013. Although the share of human insulin has
been more since FY’2008, the market captured by analog insulin has been growing
rapidly with a CAGR of 20.4% during FY’2008-FY’2013, increasing its share from
~% in FY’2008 to ~% in FY’2013.

India has become a very lucrative market for insulin
multinationals. Companies including Novo Nordisk, Eli Lilly and Sanofi dominate
the landscape and had a share of more than ~% in the Indian insulin market in
FY’2013. With superior product portfolios and marketing strategies, the 3
companies have gained a monopoly over the market. Domestic enterprises
including Biocon and Wockhardt therefore face stiff competition from the
foreign counterparts.

Key Topics Covered in
the Report
·        
The market size of India insulin market in terms
of revenue
·        
Market segmentation by insulin replacement
therapy and types of insulin
·        
Government regulation and support schemes for
the Indian insulin market
·        
Pricing scenario of different insulin brands in
India
·        
Trends and developments in India insulin market
·        
Growth drivers and challenges in India insulin
market
·        
Market share of major players in the insulin
market in India
·        
Market share of major players by types of
insulin
·        
Company profiles of major players in the Indian
insulin market
·        
Future outlook and projections of the insulin
market in India
Macroeconomic factors affecting the insulin
market in India
  








Contact:

Ken Research

Information Department

info@kenresearch.com

+91-011-47017199

Tuesday, September 23, 2014

Trends and Developments of Philippines K-12, Higher Education, Test Preparation, Technical-Vocational Training and Teacher Training Market

Philippines Education Industry Outlook to 2018 – Next Wave of Growth Driven by Test Preparation, Teacher Training and Vocational Training Segment presents a comprehensive analysis of the industry covering aspects including market size in terms of revenues, enrollments, establishments and faculty-student ratio. The report also entails a detailed analysis of the market segmentation on the basis of K-12, higher education, technical and vocational training, test preparation, private tutoring, e-learning and teacher training and education by different categories on the basis of revenues, enrollments and establishments.

The report provides the company profiles of the major players operating in the test preparation, technical-vocational training, teacher training and education, K-12, higher education and e-learning market in Philippines. The report also highlights the major trends and developments of all the segments in Philippines education industry over the years. Future analysis of the industry along with its various market segments is provided on the basis of revenues over the next five years.

Philippines education industry has showcased a significant growth in the past decade owing to the adoption of the enhanced basic education model. The financial support and aid from the foreign countries such as Australia, Canada, US and others have been aiding the Philippines government in restructuring the education system in the country. The several programs and initiatives have been taken by the Philippines government to improve the quality of education in the country. The increasing investments by the government and other local and foreign agencies for the provision of universal access to quality education at all levels to the Filipinos are likely to boost the total number of enrollments and establishments in the education industry in Philippines.

The K-12 education market has been the largest contributor to the overall revenues of the Philippines education industry. The revenues of K-12 education market were estimated to be worth USD ~ million in 2013, which grew from USD ~ million in 2008. The major growth driver in the K-12 education market was the implementation of the enhanced basic education program in Philippines. This market has been highly fragmented with the presence of large number of public and private players competing on the basis of tuition fees, infrastructure and other services. The major segments in the K-12 education market are namely kindergarten, primary and high school. Secondary level of education accounted for the majority share to the overall revenues of the K-12 education market.

The higher education market is the second largest contributor to the revenues of the Philippines education industry. The market share of the higher education market in Philippines declined to ~% in 2013. This declining market share was possibly due to the inclining tuition fees for the private and public higher education institutions. Some of the major players operating in this market are namely University of the Philippines, De La Salle University and others. This market is likely to grow at a CAGR of ~% in the next 5 years.

The technical-vocational training segment accounted for a share of ~% in 2008 which declined marginally to ~% in 2013. The major reason for this decline was the no or low fees charged by the public technical-vocational training institutions in Philippines. This market is expected to witness an increase in the revenues to USD ~ million over the period from 2013 to 2018.

The Philippines private tutoring market has contributed a share of ~% in 2008 which decreased slightly to ~% in 2013. The trend of homeschooling in Philippines can be attributed for the decline in the market share. The major players operating in the tutoring market are namely AHEAD tutorial and review center, MSA Academic Advancement Institute and others. It is expected that the private tutoring market in Philippines will grow at a CAGR of ~% during the period from 2013 to 2018.

The test preparation market has been the fifth largest market in the Philippines education industry. The market revenues for test preparation increased from USD ̴ million in 2008 to USD ~ million in 2013. The Philippines test preparation market has been dominated by the private players who compete with each other through review fees and other flexibility options in timings and scheduling classes. The significant players in the Philippines test preparation market for civil engineering review are namely Besaville Review Center, Padilla Review Center, Gillesania Review Center and others. The inclining personal disposable incomes, escalating competition have been some of the reasons for remarkable growth of this segment. This market is expected to grow at a CAGR of ~% over the period 2013-2018.

The least share has been contributed by the Philippines teacher training market in 2008. It is likely to grow gradually in the future years owing to the government initiatives and programs in this segment. The teacher education market has also been growing rapidly and is expected to maintain its growth momentum in the future years. The teacher education market has been segmented into bachelors and masters degree programs offered in the field of teacher education in Philippines.

The Philippines e-learning segment has been expanding rapidly and includes online-learning and training, software development and e-content development. This market is likely to grow at a remarkable rate in the future years.

The Philippines education industry is estimated to register escalating CAGR of ~% for the period from 2013 to 2018 with the private players established in the industry driving the enrollments in the education industry in the coming years.

Key Topics Covered in the Report

  • Market Size of Philippines Education Industry, 2008-2013
  • Market Segmentation of Philippines Education by K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning
  • Market Size of K-12 Education Market, 2008-2013
  • Market Segmentation of K-12 education Market by Kindergarten, Primary and Secondary level of education, 2008-2013
  • Market Size of Higher Education Market, 2008-2013
  • Market Segmentation of Higher education Market by Private and Public higher education institutions, 2008-2013
  • Market Size of Test Preparation Market, 2008-2013
  • Market Size of Private Tutoring Market, 2008-2013
  • Market Size of Technical and Vocation Training Market, 2008-2013
  • Market Size of Teacher Training Market, 2008-2013
  • Market Size of Teacher Education Market, 2008-2013
  • Market Segmentation of Teacher Education Market by Bachelors and Masters Degree Programs in Education, 2008-2013
  • Profiles of Major Players in Philippines K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning Market 
  • Trends and Developments of Philippines K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning Market
  • Future Outlook and Projections of K-12, Higher Education, Test Preparation, Technical-Vocational Training, Teacher Training and Education, Private Tutoring and E-learning Market in Philippines, 2014-2018

Contact: 
Ken Research
Information Department
info@kenresearch.com
+91-011-47017199

Wednesday, September 17, 2014

India Insulin Market will Exceeds USD 600 million by FY’2018: Ken Research

India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies presents a comprehensive analysis of market size by value of major types of insulin consumed in India. The report entails the segment wise market share analysis and company profiles of major players in the insulin market in India. The future analysis of the market has also been discussed in the report.

India Insulin Market
The economic advancement of any country is paradoxical in nature. While on one hand it increases the affluence of the masses, the other side is characterized by diseases that are accompanied by passive lifestyles. From the several diseases caused by a sedentary form of life such as cardiovascular ailments, hypertension and high blood pressure, diabetes is also increasing at an alarming rate, especially in the developing countries. India was resident to nearly 61.5 million people suffering from diabetes in 2013, which is the second largest in the world after China. The prevalence of diabetes has made it the fifth largest disease in India.

Diabetes in India is reaching epidemic proportions. Rapid cultural changes such as increasing urbanization, modified diet patterns and sedentary lifestyles among the young generation, have heightened the prevalence of diabetes in India. In 2013, while 61.5 million people suffered from diabetes in the country, another 30 million were in the pre-diabetes group. Medication for the diabetic population is the need of the hour since the disease is adding significantly to the mortality rate of India.

In FY’2008, the revenue generated by the sales of insulin in India was estimated to be USD ~ million and reached USD ~ million in FY’2013, following at a CAGR of 13.9% during the period. The Indian insulin market is witnessing development and has yet to mature. With a huge base of diabetic patients, it is anticipated that only 25% of this population is receiving treatment. Unawareness backed by low affordability has left the major proportion of the diabetic populace to remain untreated. However, since higher disposable income is increasing the accessibility to healthcare services, enhanced diagnostics will further broaden the patient base, creating opportunities for insulin companies operating in India.

The diabetic population in India is largely treated with human insulin solely due to the fact that it is cheaper as compared to analog insulin. In FY’2013, human insulin held ~% of the total insulin market in India, generating revenue of USD ~ million. The revenue from human insulin registered a CAGR of 10.5% during FY’2008-FY’2013. Although the share of human insulin has been more since FY’2008, the market captured by analog insulin has been growing rapidly with a CAGR of 20.4% during FY’2008-FY’2013, increasing its share from ~% in FY’2008 to ~% in FY’2013.

India has become a very lucrative market for insulin multinationals. Companies including Novo Nordisk, Eli Lilly and Sanofi dominate the landscape and had a share of more than ~% in the Indian insulin market in FY’2013. With superior product portfolios and marketing strategies, the 3 companies have gained a monopoly over the market. Domestic enterprises including Biocon and Wockhardt therefore face stiff competition from the foreign counterparts.

Key Topics Covered in the Report
·         The market size of India insulin market in terms of revenue
·         Market segmentation by insulin replacement therapy and types of insulin
·         Government regulation and support schemes for the Indian insulin market
·         Pricing scenario of different insulin brands in India
·         Trends and developments in India insulin market
·         Growth drivers and challenges in India insulin market
·         Market share of major players in the insulin market in India
·         Market share of major players by types of insulin
·         Company profiles of major players in the Indian insulin market
·         Future outlook and projections of the insulin market in India

·         Macroeconomic factors affecting the insulin market in India   

Table of Contents:
1. Asia Pacific Insulin Market Introduction
1.1. Asia Pacific Insulin Market Value Chain
1.2. Asia Pacific Insulin Market Size by Value, 2008-2013
1.3. Asia Pacific Insulin Market Segmentation, 2008-2013
1.3.1. By Geography, 2008-2013
1.3.2. By Insulin Replacement Therapy (Human Insulin and Analog Insulin), 2013
1.3.3. By Types of Insulin (Premix, Rapid Acting, Long Acting), 2013
1.4. New Product Development By Major Insulin Companies
1.5. Trends and Developments in Asia Pacific Insulin Market
Monopoly of Foreign Brands
Phasing Out of Human Insulin
1.6. Growth Drivers and Challenges in Asia Pacific Insulin Market
Shift from Human Insulin to Analog Insulin
Rising Prevalence of Diabetes
Increasing Diabetes Care Expenditure
Low Affordability
Lack of Awareness
1.7. SWOT Analysis of Asia Insulin Market
1.8. Asia Pacific Insulin Market Future Outlook and Projections, 2014-2018
1.8.1. By Geography, 2014-2018

2. India Insulin Market Introduction

3. India Insulin Market Size, FY’2008-FY’2013

4. India Insulin Market Segmentation, FY’2008-FY’2013
4.1. By Insulin Replacement Therapy (Human Insulin and Analog Insulin), FY’2008-FY’2013
4.2. By Types of Insulin (Premix, Rapid Acting, long Acting), FY’2008-FY’2013
4.3. Usage by Type of Diabetes, FY’2008-FY’2013

5. Government Regulations and Support Schemes in India Insulin Market
5.1. National Pharmaceutical Pricing Authority (NPPA) 
Implications of Pricing Limits by NPPA
5.2. National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) 

6. Pricing Scenario in India Insulin Market

7. Trends and Developments in India Insulin Market
Price Gap Between Foreign and Domestic Insulin Brands
Shift of Diabetes to Young Age Group
Strategic Alliances in India Insulin Market

8. Growth Drivers and Challenges in India Insulin Market
Increasing Diabetic Population
Increasing Expenditure on Diabetes Care
Exchange Rate Fluctuation

9. Market Share of Major Companies in India Insulin Market, FY’2013
9.1. By Type of Insulin, FY’2013
9.1.1. By Premix Insulin, FY’2013
9.1.2. By Long Acting Insulin, FY’2013
9.1.3. By Rapid Acting Insulin, FY’2013

10. Company Profiles of Major Players in India Insulin Market
10.1. Novo Nordisk India Pvt. Ltd
10.1.1. Company Overview
10.1.2. Business Strategies
Market Expansion Through Spreading Awareness
Strengthening Research and Development (R&D) Activities
10.1.3. Competitive Standing
10.2. Eli Lilly and Company India Pvt. Ltd. 
10.2.1. Company Overview
10.2.2. Business Strategies
Focus on Increasing R&D Investment in India
Concentration Towards the Diabetes Care Segment
10.2.3. Competitive Standing
10.3. Sanofi India Ltd. 
10.3.1. Company Overview
10.3.2. Business Strategies
Commence Insulin Production in India
Product Innovation
Patient Awareness Programs
10.3.3. Competitive Standing
10.4. Biocon Ltd. 
10.4.1. Company Overview
10.4.2. Competitive Standing
10.5. Wockhardt Ltd. 
10.5.1. Company Overview
10.5.2. Competitive Standing

11. India Insulin Market Future Outlook and Projections, 2014-2018
11.1. By Insulin Replacement Therapy (Human Insulin and Analog Insulin, FY’2014-FY’2018
11.2. Cause and Effect Relationship Between Dependable and Independent Variable Factors prevailing in India Insulin Market

12. Macroeconomic Factors in India Insulin Market, 2008-2018
12.1. Diabetic Population in India, 2008-2018
12.2. India Government Spending on Healthcare, FY’2008-FY’2018
12.3. India Consumer Spending on Healthcare, FY’2008-FY’2018
12.4. India Personal Disposable Income, FY’2008-FY’2018

13. Appendix
13.1. Market Definitions
13.2. Abbreviations
13.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent) 
Final Conclusion
13.4. Disclaimer


Contact:
Ken Research
Information Department
info@kenresearch.com
+91-011-47017199